These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 38580795)

  • 1. CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.
    Sun M; Manson ML; Guo T; de Lange ECM
    CNS Drugs; 2024 May; 38(5):349-373. PubMed ID: 38580795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Antiviral Medicinal Plants and Biological Compounds Against Central Nervous System Infections: A Mechanistic Review.
    Malekmohammad K; Rafieian-Kopaei M; Sardari S; Sewell RDE
    Curr Drug Discov Technol; 2020; 17(4):469-483. PubMed ID: 31309894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses.
    Liu BM; Mulkey SB; Campos JM; DeBiasi RL
    Pediatr Res; 2024 Jan; 95(2):543-550. PubMed ID: 38042947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.
    Studahl M; Lindquist L; Eriksson BM; Günther G; Bengner M; Franzen-Röhl E; Fohlman J; Bergström T; Aurelius E
    Drugs; 2013 Feb; 73(2):131-58. PubMed ID: 23377760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illuminating viral infections in the nervous system.
    McGavern DB; Kang SS
    Nat Rev Immunol; 2011 May; 11(5):318-29. PubMed ID: 21508982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Therapies for Neurotropic Viral Infections: Mechanisms, Challenges, and Future Prospects.
    Yang M; Ding C; Zhao T; Song G; Liu T; Li Z; Zhang Y
    Rev Med Virol; 2024 Sep; 34(5):e2575. PubMed ID: 39160646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches and challenges to treatment of central nervous system viral infections.
    Nath A; Tyler KL
    Ann Neurol; 2013 Sep; 74(3):412-22. PubMed ID: 23913580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotypic Brain Cultures: A Framework for Studying CNS Infection by Neurotropic Viruses and Screening Antiviral Drugs.
    Welsch JC; Lionnet C; Terzian C; Horvat B; Gerlier D; Mathieu C
    Bio Protoc; 2017 Nov; 7(22):e2605. PubMed ID: 34595280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchestration of antiviral responses within the infected central nervous system.
    Pavlou A; Mulenge F; Gern OL; Busker LM; Greimel E; Waltl I; Kalinke U
    Cell Mol Immunol; 2024 Sep; 21(9):943-958. PubMed ID: 38997413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transmission routes of neuropathogenic pathogens-Possible mechanisms of neuroinvasion].
    Craemer EM
    Nervenarzt; 2023 Apr; 94(4):296-305. PubMed ID: 36690702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.
    Durrant DM; Ghosh S; Klein RS
    ACS Chem Neurosci; 2016 Apr; 7(4):464-9. PubMed ID: 27058872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.
    Banks WA
    J Neurovirol; 1999 Dec; 5(6):538-55. PubMed ID: 10602396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of viral infections of the central nervous system.
    Griffin DE
    Antiviral Res; 1991 Jan; 15(1):1-10. PubMed ID: 1903621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral type I and type III interferon responses in the central nervous system.
    Sorgeloos F; Kreit M; Hermant P; Lardinois C; Michiels T
    Viruses; 2013 Mar; 5(3):834-57. PubMed ID: 23503326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Next-Generation Sequencing for the Diagnosis of Infections of the Central Nervous System Caused by the Neurotropic Herpes Viruses: A Pilot Study.
    Xing XW; Zhang JT; Ma YB; Chen XY; Wu L; Wang XL; Wang HF; Wang RF; Yang F; Yu SY
    Eur Neurol; 2018; 80(5-6):283-288. PubMed ID: 30763937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinvasion and Inflammation in Viral Central Nervous System Infections.
    Dahm T; Rudolph H; Schwerk C; Schroten H; Tenenbaum T
    Mediators Inflamm; 2016; 2016():8562805. PubMed ID: 27313404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral interactions with the blood-brain barrier: old dog, new tricks.
    Hou J; Baker LA; Zhou L; Klein RS
    Tissue Barriers; 2016; 4(1):e1142492. PubMed ID: 27141421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RVG Peptide-Functionalized Favipiravir Nanoparticle Delivery System Facilitates Antiviral Therapy of Neurotropic Virus Infection in a Mouse Model.
    Ren M; Zhou Y; Tu T; Jiang D; Pang M; Li Y; Luo Y; Yao X; Yang Z; Wang Y
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.